Ident. | Authors (with country if any) | Title |
---|
000009 (2020) |
B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine] | [Pharmacotherapeutics for the New Coronavirus Pneumonia]. |
000016 (2020) |
Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
000043 (2020) |
Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan] | The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. |
000049 (2020) |
Suliman Khan [République populaire de Chine] ; Rabeea Siddique [République populaire de Chine] ; Muhammad Adnan Shereen [République populaire de Chine] ; Ashaq Ali [République populaire de Chine] ; Jianbo Liu ; Qian Bai [République populaire de Chine] ; Nadia Bashir [République populaire de Chine] ; Mengzhou Xue [République populaire de Chine] | The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. |
000066 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
000103 (2020) |
Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz Feldmann | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |
000118 (2020) |
Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande] | Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). |
000129 (2020) |
Zachary J. Sandler [États-Unis] ; Mason R. Firpo [États-Unis] ; Oreoluwa S. Omoba [États-Unis] ; Michelle N. Vu [États-Unis] ; Vineet D. Menachery [États-Unis] ; Bryan C. Mounce [États-Unis] | Novel ionophores active against La Crosse virus identified through rapid antiviral screening. |
000130 (2020) |
Jahan S. Khalili [États-Unis] ; Hai Zhu [États-Unis] ; Nga Sze Amanda Mak [États-Unis] ; Yongqi Yan [États-Unis] ; Yi Zhu [États-Unis] | Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. |
000140 (2020) |
Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine] | Molecular immune pathogenesis and diagnosis of COVID-19 |
000159 (2020) |
Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde] | Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. |
000175 (2020) |
Bhumi Shah [Inde] ; Palmi Modi [Inde] ; Sneha R. Sagar [Inde] | In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. |
000178 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
000246 (2020) |
Pradip Dashraath [Singapour] ; Wong Jing Lin Jeslyn [Singapour] ; Lim Mei Xian Karen [Singapour] ; Lim Li Min [Singapour] ; Li Sarah [Singapour] ; Arijit Biswas [Singapour] ; Mahesh Arjandas Choolani [Singapour] ; Citra Mattar [Singapour] ; Su Lin Lin [Singapour] | Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. |
000249 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
000254 (2020) |
Timothy P. Sheahan [États-Unis] ; Amy C. Sims [États-Unis] ; Sarah R. Leist [États-Unis] ; Alexandra Sch Fer [États-Unis] ; John Won [États-Unis] ; Ariane J. Brown [États-Unis] ; Stephanie A. Montgomery [États-Unis] ; Alison Hogg [États-Unis] ; Darius Babusis [États-Unis] ; Michael O. Clarke [États-Unis] ; Jamie E. Spahn [États-Unis] ; Laura Bauer [États-Unis] ; Scott Sellers [États-Unis] ; Danielle Porter [États-Unis] ; Joy Y. Feng [États-Unis] ; Tomas Cihlar [États-Unis] ; Robert Jordan [États-Unis] ; Mark R. Denison [États-Unis] ; Ralph S. Baric [États-Unis] | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV |
000255 (2020) |
Barry Rockx [Pays-Bas] ; Thijs Kuiken [Pays-Bas] ; Sander Herfst [Pays-Bas] ; Theo Bestebroer [Pays-Bas] ; Mart M. Lamers [Pays-Bas] ; Bas B. Oude Munnink [Pays-Bas] ; Dennis De Meulder [Pays-Bas] ; Geert Van Amerongen [Pays-Bas] ; Judith Van Den Brand [Pays-Bas] ; Nisreen M A. Okba [Pays-Bas] ; Debby Schipper [Pays-Bas] ; Peter Van Run [Pays-Bas] ; Lonneke Leijten [Pays-Bas] ; Reina Sikkema [Pays-Bas] ; Ernst Verschoor [Pays-Bas] ; Babs Verstrepen [Pays-Bas] ; Willy Bogers [Pays-Bas] ; Jan Langermans [Pays-Bas] ; Christian Drosten [Allemagne] ; Martje Fentener Van Vlissingen [Pays-Bas] ; Ron Fouchier [Pays-Bas] ; Rik De Swart [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] | Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. |
000263 (2020) |
Sheng-Qun Deng ; Hong-Juan Peng | Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China |
000276 (2020) |
Balachandar Vellingiri [Inde] ; Kaavya Jayaramayya [Inde] ; Mahalaxmi Iyer [Inde] ; Arul Narayanasamy [Inde] ; Vivekanandhan Govindasamy [Inde] ; Bupesh Giridharan [Inde] ; Singaravelu Ganesan [Inde] ; Anila Venugopal [Inde] ; Dhivya Venkatesan [Inde] ; Harsha Ganesan [Inde] ; Kamarajan Rajagopalan [Inde] ; Pattanathu K. S. M. Rahman [Royaume-Uni] ; Ssang-Goo Cho [Corée du Sud] ; Nachimuthu Senthil Kumar [Inde] ; Mohana Devi Subramaniam [Inde] | COVID-19: A promising cure for the global panic |
000280 (2020) |
Mazin Barry ; Maha Al Amri ; Ziad A. Memish | COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. |
000287 (2020) |
Jimin Xu ; Pei-Yong Shi [États-Unis] ; Hongmin Li [États-Unis] ; Jia Zhou [États-Unis] | Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic
Potential |
000307 (2020) |
Yung-Fang Tu [Taïwan] ; Chian-Shiu Chien [Taïwan] ; Aliaksandr A. Yarmishyn [Taïwan] ; Yi-Ying Lin [Taïwan] ; Yung-Hung Luo [Taïwan] ; Yi-Tsung Lin [Taïwan] ; Wei-Yi Lai [Taïwan] ; De-Ming Yang [Taïwan] ; Shih-Jie Chou [Taïwan] ; Yi-Ping Yang [Taïwan] ; Mong-Lien Wang [Taïwan] ; Shih-Hwa Chiou [Taïwan] | A Review of SARS-CoV-2 and the Ongoing Clinical Trials. |
000315 (2020) |
Robyn Ralph [Canada] ; Jocelyne Lew [Canada] ; Tiansheng Zeng [République populaire de Chine] ; Magie Francis [Canada] ; Bei Xue [République populaire de Chine] ; Melissa Roux [Canada] ; Ali Toloue Ostadgavahi [Canada] ; Salvatore Rubino [Italie] ; Nicholas J. Dawe [Canada] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; David J. Kelvin [République populaire de Chine] ; Christopher D. Richardson [Canada] ; Jason Kindrachuk [Canada] ; Darryl Falzarano [Canada] ; Alyson Anne Kelvin [Canada] | 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. |
000361 (2019) |
Myung Hee Kim [Corée du Sud] ; Hyun Jik Kim [Corée du Sud] ; Jun Chang [Corée du Sud] | Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus |
000406 (2019) |
Sinosh Skariyachan ; Sneha Basavaraj Challapilli ; Swathi Packirisamy ; Supreetha Toplar Kumargowda ; Vaishnavi Sneha Sridhar | Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections |
000408 (2019) |
Olujide O. Olubiyi [Nigeria] ; Maryam O. Olagunju ; Birgit Strodel [Allemagne] | Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease |
000437 (2019) |
Sabeena Mustafa [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite] ; Musa Gabere [Arabie saoudite] | Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach |
000439 (2019) |
Chuanyan Wu [République populaire de Chine, Suède] ; Rui Gao [République populaire de Chine] ; Yusen Zhang [République populaire de Chine] ; Yang De Marinis [Suède] | PTPD: predicting therapeutic peptides by deep learning and word2vec |
000456 (2019) |
Yan-Hua Li [République populaire de Chine] ; Chen-Yu Hu [République populaire de Chine] ; Nan-Ping Wu [République populaire de Chine] ; Hang-Ping Yao [République populaire de Chine] ; Lan-Juan Li [République populaire de Chine] | Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins |
**** probable Xml problem ****
000461 |
|